#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
How is hemangiopericytoma diagnosed?
In addition to a complete medical history and physical examination, the most conclusive diagnostic procedure for hemangiopericytoma is a biopsy—a single tissue sample taken from the tumor through a simple surgical procedure.
The tumor's cellular appearance under a microscope enables doctors to distinguish it from other types of cancer and determine whether it is malignant or benign. Your child will likely have various imaging studies that will include one or more of the following:
If your child’s doctor determines that the hemangiopericytoma is malignant, the tumor is staged. This process indicates how far the tumor has spread from its original location.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”